Advertisement
Advertisement
KROS
Keros Therapeutics, Inc. Common Stock
9.33
USDSponsored
+0.16
+1.74%
Nov 10, 15:59 UTC -5
Closed
After-Market
9.32
-0.01
-0.05%
Keros Therapeutics, Inc. Common Stock (KROS)
Keros Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 183M |
| Beta | 1.13 |
| Earnings Per Share (EPS) | -2.82 |
| Price-to-Book (P/B) Ratio | 0.82 |
| Operating Margin | -256.60% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -21.40% |
| Current Ratio | 21.96% |
| Free Cash Flow | -24.18M |
